Women-founded company partners with CU Anschutz to develop, test first-of-its-kind ovarian cancer detection test
Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...
Experimental women's cancer drug boosts survival rates in notable study
A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.
Corcept's ovarian cancer drug meets main goal in late-stage study, shares jump
Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a ...
The Healthy @Reader's Digest5d
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
A common blood test for ovarian cancer is more likely to fall short for Black and Native American women
A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
GlobalData on MSN16h
Corcept’s Phase III trial of ovarian cancer therapy shows PFS improvement
The trial outcomes are said to support a new drug application in the US and a European marketing authorisation application.
Explore more
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
Blood test for ovarian cancer misses some Black and Native American patients, study finds
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...
The Associated Press on MSN12d
Blood test for ovarian cancer misses some Black, Native American patients: Study
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...